Doctor profile · Federal record
Dr. Sabah Shah, M.D., M.B.A.
Ophthalmology Physician (CMS: Ophthalmology) · Slingerlands, NY
- NPI 1588983175
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1220 New Scotland RD Ste 201
Slingerlands, NY 121599386
(518) 533-6550 - Additional location
-
222 E 41St St
New York, NY 100176739
(212) 263-2574
Credentials & registration
- NPI registered
- May 2010 — 16 yrs on file
- Profile last updated
- September 6, 2022
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- New York #274673
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588983175. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
14,635
Distinct HCPCS
10
Medicare allowed
$1,634,231
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 9,062 | 52 | $37 | |
92134 |
Imaging of retina | 1,708 | 797 | $46 | |
J0178 |
Injection, aflibercept, 1 mg | 972 | 159 | $846 | |
67028 |
Injection of drug into eye | 761 | 255 | $137 | |
92012 |
Established patient problem focused exam of visual system | 502 | 374 | $104 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 363 | 288 | $104 | |
92201 |
Extended exam of the back part of the eye with retinal drawing | 312 | 300 | $28 | |
92014 |
Established patient complete exam of visual system | 265 | 253 | $146 | |
92235 |
Exam of retinal blood vessels using a special camera after injection of a dye | 212 | 183 | $162 | |
J9035 |
Injection, bevacizumab, 10 mg | 131 | 43 | $68 |
In context: peer comparison
Among 2 peers in Slingerlands Ophthalmology Physician, average services per provider: 490. This provider delivers 30× the peer median.Open Payments
Industry payments received
All-time total
$15,568
Transactions
86
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genentech USA, INC. | 18 | $10,208.44 | |
| Regeneron Healthcare Solutions, INC. | 13 | $3,674.30 | |
| Mallinckrodt Hospital Products INC. | 19 | $648.55 | |
| Astellas Pharma US INC | 8 | $340.11 | |
| Alimera Sciences, INC. | 4 | $173.87 | |
| Abbvie INC. | 5 | $110.39 | |
| Oyster Point Pharma, INC. | 3 | $77.30 | |
| Apellis Pharmaceuticals, INC. | 3 | $60.65 | |
| Dompe US, INC. | 2 | $54.93 | |
| Bausch & Lomb Americas INC. | 3 | $54.90 | |
| Ani Pharmaceuticals, INC. | 2 | $43.31 | |
| Alcon Vision LLC | 2 | $40.14 | |
| Sun Pharmaceutical Industries INC. | 2 | $29.67 | |
| Tarsus Pharmaceuticals, INC. | 1 | $28.47 | |
| Abbott Laboratories | 1 | $23.45 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
204
Patients
101
Total drug cost
$27,055
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 60 | 32 | $2,282 |
| Prolensa (Bromfenac Sodium) | Brand | 53 | 18 | $18,451 |
| Ofloxacin | Generic | 19 | 15 | $311 |
| Latanoprost | Generic | 18 | 11 | $158 |
| Difluprednate | Generic | 16 | 12 | $2,771 |
| Atropine Sulfate | Generic | 15 | 13 | $762 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 12 | 0 | $274 |
| Loteprednol Etabonate | Generic | 11 | 0 | $2,046 |
Frequently asked questions
What is Dr. Sabah Shah's medical specialty?
Dr. Sabah Shah practices Ophthalmology Physician in Slingerlands, NY.
Where does Dr. Sabah Shah practice?
Dr. Sabah Shah practices at 1220 New Scotland RD Ste 201, Slingerlands, NY 121599386. Office phone: 5185336550.
What is Dr. Sabah Shah's NPI?
Dr. Sabah Shah's National Provider Identifier (NPI) is 1588983175, issued by NPPES.
Does Dr. Sabah Shah accept Medicare assignment?
Yes. Dr. Sabah Shah accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sabah Shah commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, aflibercept, 1 mg (HCPCS J0178). Source: CMS Medicare Physician & Other Practitioners file.